Fluconazole

DB00196ApprovedInvestigationalSmall moleculeAntifungal AgentsAzole Antifungals

Fluconazole is a triazole antifungal used to treat various fungal infections including candidiasis. It was initially approved by the FDA in 1990.

Chemical structure of Fluconazole
Mechanism
Curator reviewed · 6 references
Primary indication
Fluconazole can be administered in the treatment of the following fungal infections: 1) Vaginal yeast infections caused by Candida 2) Systemic Candida infections 3) Both esophageal and oropharyngeal candidiasis 4) Cryptococcal meningitis 5) UTI (urinary...Curator reviewed · 29 structured indications
Formula / weight
C13H12F2N6O · 306.2708 g/mol (avg)
First approval
Canada, 2002 · United States, 1990
Also known as
Diflucan · Difluconazole · Triflucan
Code names
UK-49,858
Brand names
  • Diflucan

Resolves to

Structure
InChIKeyRFHAOTPXVQNOHP-UHFFFAOYSA-NSMILESOC(CN1C=NC=N1)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1
Transporters

What you can answer from here — as of September 16, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1TransporterSubstrate / inhibitor direction, not just membership
Listed above
1,903Drug interactionsStructured to mechanism, not free text
Sign in
203Clinical trialsPhase, status and sponsor resolved per trial
Sign in
29Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
8ContraindicationsEach with its own population and attribute set
Sign in
2,006Marketed productsAcross 11 countries and 304 labellers
Sign in
3ATC codesIncluding every combination product, plus 34 drug categories
Sign in
59+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Fluconazole, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account